ClinicalTrials.Veeva

Menu

Fabry Disease Screening in ESRD Patients in West of France (SNOUFY)

R

Rennes University Hospital

Status

Completed

Conditions

ESRD

Treatments

Other: Dried blood spot test

Study type

Observational

Funder types

Other

Identifiers

NCT02719249
35RC14-9733

Details and patient eligibility

About

Screening of Fabry disease in end-stage renal disease (ESRD) patients on dialysis or transplant in west of France.

Full description

Detection of Fabry disease is done by dried blood spot test, in dialyzed and transplanted men, who reached ESRD for vascular or unknown disease and were not previously screened.

Enrollment

500 patients

Sex

Male

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men less than 70 years old
  • ESRD treated by dialysis or kidney graft in one of the 4 following regions : Bretagne, Centre, Pays de la Loire and Poitou-Charentes
  • For unknown nephropathy OR vascular nephropathy and/or diabetic nephropathy unproved by biopsy
  • Agreeing freely to participate in the study

Exclusion criteria

  • Men less than 18 years old
  • Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty.

Trial design

500 participants in 1 patient group

Men with ESRD on dialysis or transplant
Treatment:
Other: Dried blood spot test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems